MedPath

The Efficacy of SinoFresh Nasal and Sinus Care Nasal Spray in Eliminating MRSA From the Nasal Cavity

Not Applicable
Withdrawn
Conditions
MRSA Infection
Interventions
Drug: Sinofresh
Drug: Placebo
Registration Number
NCT00790972
Lead Sponsor
University of Chicago
Brief Summary

This is a study to assess the ability of SinoFresh Nasal \& Sinus Care, an FDA approved over-the-counter nasal spray, to eliminate the bacteria in your nose.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • 18 years or older
  • The volunteer is able to adhere to the study requirements and study visits.
  • Agrees to abstain from use of other nasal sprays for length of study.
  • Diagnosis of an MRSA carrier by PCR testing
Exclusion Criteria
  • History of chronic nose bleeds.
  • History of intranasal steroids in the last 2 months
  • Nasal obstruction severe enough to prohibit effective delivery of a nasal spray
  • Epistaxis
  • Significant excoriation in the opinion of the Investigator.
  • Known hypersensitivity to any ingredients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Sinofreshtwo sprays in each nostril three times daily for one week
2PlaceboIdentical-appearing placebo
Primary Outcome Measures
NameTimeMethod
This is a study to assess the ability of SinoFresh Nasal & Sinus Care, an FDA approved over-the-counter nasal spray, to eliminate the bacteria in your nose.7 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The University of Chicago

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath